Ignite Creation Date:
2025-12-24 @ 2:23 PM
Ignite Modification Date:
2026-01-10 @ 4:14 PM
Study NCT ID:
NCT00285259
Status:
COMPLETED
Last Update Posted:
2024-10-21
First Post:
2006-01-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)
Sponsor:
Astellas Pharma Inc
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | cytomegalovirus infection | View |
| None | infectious disease | View |
| None | viremia | View |
| None | cytomegalovirus disease | View |
| None | stem cell transplant | View |
| None | allogeneic | View |
| None | bone marrow transplant | View |
| None | hematopoietic cell transplant | View |
| None | Acute Lymphoblastic Leukemia | View |
| None | Chronic Myelogenous Leukemia | View |
| None | Acute Myelogenous Leukemia | View |
| None | Hodgkin's Lymphoma | View |
| None | Non-Hodgkin's Lymphoma | View |
| None | Myelodysplastic Syndrome | View |